ATLAS
LIVE

Serial Number

99401036

Owner

Innovaccer Inc.

Attorney

Daniel H. Landau

Filing Date

Sep 18, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ATLAS Trademark

Serial Number: 99401036

ATLAS is a trademark filed by Innovaccer Inc. on September 18, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Innovaccer Inc. (49 trademarks)

#701, 2120 University Ave
Berkeley, CA 94704

Entity Type: 03

Trademark Details

Filing Date

September 18, 2025

Registration Date

Not Registered

Goods & Services

Business administration services in the field of population-level healthcare

Downloadable computer software for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Downloadable computer software using artificial intelligence (AI) for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Downloadable cloud-computing software for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; all excluding the fields of individual patient medical information, records, care, treatment, testing, monitoring, sample collection; all excluding laboratory use, all excluding the fields of bioinformatics, pharmaceuticals, and genetic data analysis, testing, sampling, and monitoring

Platform as a service (PAAS) featuring computer software platforms for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Cloud computing featuring software for use with value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Software as a service (SAAS) services featuring software for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Providing on-line non-downloadable software using artificial intelligence (AI) for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for value-based care design, execution, and settlement, benchmarking and competitive intelligence, population health analytics, predictive analytics and risk modeling, risk adjustment, quality management, cost management, utilization management, and compliance and regulatory reporting in the field of population-level healthcare, all excluding the fields of individual patient medical information, records, care, treatment, testing, monitoring, sample collection; all excluding laboratory use; all excluding the fields of bioinformatics, pharmaceuticals, and genetic data analysis, testing, sampling, and monitoring

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 9, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 9, 2026 GNSL
SUSPENSION LETTER WRITTEN
Feb 9, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 6, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 6, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 6, 2025 GNRN
NON-FINAL ACTION E-MAILED
Oct 6, 2025 GNRT
NON-FINAL ACTION WRITTEN
Oct 6, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 3, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 18, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 18, 2025 NWOS
NEW APPLICATION ENTERED
Sep 18, 2025 NWAP